Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-07-17

Clinical Trial Update: Evaluate Bacteriophage as a Useful Immunogen in Patients With Primary Immune Deficiency Diseases (PIDD) [NA]

View source ↗

Summary

Clinical trial investigating the use of bacteriophage as an immunogen in patients with primary immunodeficiency diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of South Florida | Conditions: Primary Immune Deficiency Diseases | NA | Status: UNKNOWN